Nursing Interventions for Alzheimer's Patients During PET/CT Imaging

Официальное название

Enhancing Nursing Interventions for Alzheimer's Patients During PET/CT Imaging: Effects on Image Quality and Patient Satisfaction

Обзор

The impact of nursing Interventions during PET/CT imaging in Alzheimer's patients on image quality and patient satisfaction will be assessed in 200 patients.

Подробное описание

This study will analyze clinical data from 200 Alzheimer's disease (AD) patients who underwent PET imaging and were admitted to Sichuan Provincial People's Hospital over a period of six months. The control group will receive routine nursing intervention, while the observation group will receive a refined specialized nursing intervention. We will meticulously compare various performance aspects in both groups to assess the impact of refined specialized nursing intervention on patients' image quality and patient satisfaction.

Вмешательства

• Другое Effects on Image Quality and Patient Satisfaction
  Effect of nursing intervention on image quality and patient satisfaction during PET/CT imaging in Alzheimer's patients
• Другое Anxiety degree of patients after nursing
  Self Rating Anxiety will be used Scale (SAS) to assess the degree of anxiety after care

Первичные конечные точки

• Comparison of refined nursing and routine nursing intervention in Alzheimer's Patients during PET/CT Imaging [Срок оценки: through study completion, an average of 6 months]

Критерии участия

Критерии включения

• Meet the criteria for diagnosing dementia as described in the fourth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-R), Use the diagnostic criteria for AD from the National Institute of Neurology, Speech and Communication Disorders and Stroke - Alzheimer's Disease and Related Disorders (NINCDS-ADRDA) or the National Institute on Aging and Alzheimer's Disease Association (NIA-AA).

Критерии исключения

• Patients with a history of stroke and focal neurological signs, and imaging findings consistent with small cerebral vascular disease (Fazekas score ≥2);
• The presence of other neurological disorders that can cause brain dysfunction (e.g., depression, brain tumors, Parkinson's disease, metabolic encephalopathy, encephalitis, multiple sclerosis, epilepsy, brain trauma, Normal facial pressure hydrocephalus);
• The presence of other systemic diseases that can cause cognitive impairment (such as liver insufficiency, renal insufficiency, thyroid dysfunction, severe anemia, folic acid or vitamin B12 deficiency, syphilis, HIV infection, alcohol and drug abuse, etc.);
• There is mental and neurological retardation.
• There are other diseases that are known to cause cognitive impairment.

Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.

Здоровые добровольцы: Нет

Дизайн исследования

Распределение

Рандомизированное

Модель

Параллельные группы

Маскирование

Простое слепое

Основная цель

Поддерживающая терапия

Центры проведения

Китай · 1 центр

• Departments of Nuclear Medicine, Sichuan Provincial People's Hospital — Чэнду

Идентификаторы

NCT: NCT06784830 · SichuanPPH-HL

Первоисточники (государственные реестры)

• ClinicalTrials.gov (NIH, США)

Открыть это исследование на ClinicalTrials.gov ↗